Review of available synchronization and time distribution techniques

The methods of synchronizing precision clocks will be reviewed placing particular attention to the simpler techniques, their accuracies, and the approximate cost of equipment. The more exotic methods of synchronization are discussed in lesser detail. The synchronization techniques that will be covered will include satellite dissemination, communication and navigation transmissions via VLF, LF, HF, UHF and microwave as well as commercial and armed forces television. Portable clock trips will also be discussed

Edge helicons and repulsion of fundamental edge magnetoplasmons in the quantum Hall regime

A quasi-microscopic treatment of edge magnetoplasmons (EMP) is presented for very low temperatures and confining potentials smooth on the scale of the magnetic length $\ell_{0}$ but sufficiently steep at the edges such that Landau level (LL) flattening can be discarded. The profile of the unperturbed electron density is sharp and the dissipation taken into account comes only from electron intra-edge and intra-LL transitions due to scattering by acoustic phonons. For wide channels and filling factors $\nu =1$ and 2, there exist independent EMP modes spatially symmetric and antisymmetric with respect to the edge. Some of these modes, named edge helicons, can propagate nearly undamped even when the dissipation is strong. Their density profile changes qualitatively during propagation and is given by a rotation of a complex vector function. For $\nu >2,$ the Coulomb coupling between the LLs leads to a repulsion of the uncoupled fundamental LL modes: the new modes have very different group velocities and are nearly undamped. The theory accounts well for the experimentally observed plateau structure of the delay times as well as for the EMP's period and decay rates.Comment: 12 pages, 6 figure

Instabilities and waves in thin films of living fluids

We formulate the thin-film hydrodynamics of a suspension of polar self-driven particles and show that it is prone to several instabilities through the interplay of activity, polarity and the existence of a free surface. Our approach extends, to self-propelling systems, the work of Ben Amar and Cummings [Phys Fluids 13 (2001) 1160] on thin-film nematics. Based on our estimates the instabilities should be seen in bacterial suspensions and the lamellipodium, and are potentially relevant to the morphology of biofilms. We suggest several experimental tests of our theory.Comment: 4 pages, pdflatex, accepted for publication in Phys Rev Let

Field Dependent Phase Diagram of the Quantum Spin Chain (CH3)2NH2CuCl3

Although (CH3)2NH2CuCl3 (MCCL) was first examined in the 1930's [1], there are open questions regarding the magnetic dimensionality and nature of the magnetic properties. MCCL is proposed to be a S=1/2 alternating ferromagnetic antiferromagnetic spin chain alternating along the crystalline a-axis [2,3]. Proposed ferromagnetic (JFM =1.3 meV) and antiferromagnetic (JAFM =1.1 meV) exchange constants make this system particularly interesting for experimental study. Because JFM and JAFM are nearly identical, the system should show competing behavior between S=1/2 (AFM) and S=1(FM) effects. We report low temperature magnetic field dependent susceptibility, chi(H), and specific heat, Cp, of MCCL. These provide an initial magnetic-field versus temperature phase diagram. A zero-field phase transition consistent with long range magnetic order is observed at T=0.9 K. The transition temperature can be reduced via application of a magnetic field. We also present comparisons to a FM/AFM dimer model that accounts for chi(T,H=0) and Cp(H,T).Comment: 2 pages, 1 figure included in text. Submitted to proceedings of 24th International Conference on Low Temperature Physics, August 200

Fast drift kilometric radio bursts and solar proton events

Initial results of a comparative study of major fast drift kilometric bursts and solar proton events from Sep. 1978 to Feb. 1983 are presented. It was found that only about half of all intense, long duration ( 40 min above 500 sfu) 1 MHz bursts can be associated with F 20 MeV proton events. However, for the subset of such fast drift bursts accompanied by metric Type 2 and/or 4 activity (approximately 40% of the total), the degree of association with 20 MeV events is 80%. For the reverse association, it was found that proton events with J( 20 MeV) 0.01 1 pr cm(-2)s(-1)sr(-1)MeV(-1) were typically (approximately 80% of the time) preceded by intense 1 MHz bursts that exceeded the 500 sfu level for times 20 min (median duration approximately 35 min)

Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia

Community-acquired pneumonia (CAP)/community-acquired bacterial pneumonia (CABP) and complicated skin and soft tissue infection (cSSTI)/acute bacterial skin and skin structure infection (ABSSSI) represent major causes of morbidity and mortality in children. β-Lactams are the cornerstone of antibiotic treatment for many serious bacterial infections in children; however, most of these agents have no activity against methicillin-resistant Staphylococcus aureus (MRSA). Ceftaroline fosamil, a β-lactam with broad-spectrum in vitro activity against Gram-positive pathogens (including MRSA and multidrug-resistant Streptococcus pneumoniae) and common Gram-negative organisms, is approved in the European Union and the United States for children with CAP/CABP or cSSTI/ABSSSI. Ceftaroline fosamil has completed a pediatric investigation plan including safety, efficacy, and pharmacokinetic evaluations in patients with ages ranging from birth to 17 years. It has demonstrated similar clinical and microbiological efficacy to best available existing treatments in phase III–IV trials in patients aged ≥ 2 months to < 18 years with CABP or ABSSSI, with a safety profile consistent with the cephalosporin class. It is also approved in the European Union for neonates with CAP or cSSTI, and in the US for neonates with ABSSSI. Ceftaroline fosamil dosing for children (including renal function adjustments) is supported by pharmacokinetic/pharmacodynamic modeling and simulations in appropriate age groups, and includes the option of 5- to 60-min intravenous infusions for standard doses, and a high dose for cSSTI patients with MRSA isolates, with a ceftaroline minimum inhibitory concentration of 2–4 mg/L. Considered together, these data suggest ceftaroline fosamil may be beneficial in the management of CAP/CABP and cSSTI/ABSSSI in children

The geometry in Plato's Meno

In this paper, we analyze the two geometrical passages in Plato's Meno, (81c -- 85c) and (86e4 -- 87b2), from the points of view of a geometer in Plato's time and today. We give, in our opinion, a complete explanation of the difficult second geometrical passage. Our explanation solves an ingenious geometry puzzle that has baffled readers of Plato's Meno for over 2,400 years.Comment: 50 pages, 21 figure

Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis

Human African trypanosomiasis, or sleeping sickness, is caused by the protozoan parasites <i>Trypanosoma brucei rhodesiense</i> or <i>Trypanosoma brucei gambiense</i>, and is a major cause of systemic and neurological disability throughout sub-Saharan Africa. Following early-stage disease, the trypanosomes cross the blood-brain barrier to invade the central nervous system leading to the encephalitic, or late stage, infection. Treatment of human African trypanosomiasis currently relies on a limited number of highly toxic drugs, but untreated, is invariably fatal. Melarsoprol, a trivalent arsenical, is the only drug that can be used to cure both forms of the infection once the central nervous system has become involved, but unfortunately, this drug induces an extremely severe post-treatment reactive encephalopathy (PTRE) in up to 10% of treated patients, half of whom die from this complication. Since it is unlikely that any new and less toxic drug will be developed for treatment of human African trypanosomiasis in the near future, increasing attention is now being focussed on the potential use of existing compounds, either alone or in combination chemotherapy, for improved efficacy and safety. The kynurenine pathway is the major pathway in the metabolism of tryptophan. A number of the catabolites produced along this pathway show neurotoxic or neuroprotective activities, and their role in the generation of central nervous system inflammation is well documented. In the current study, Ro-61-8048, a high affinity kynurenine-3-monooxygenase inhibitor, was used to determine the effect of manipulating the kynurenine pathway in a highly reproducible mouse model of human African trypanosomiasis. It was found that Ro-61-8048 treatment had no significant effect (P = 0.4445) on the severity of the neuroinflammatory pathology in mice during the early central nervous system stage of the disease when only a low level of inflammation was present. However, a significant (P = 0.0284) reduction in the severity of the neuroinflammatory response was detected when the inhibitor was administered in animals exhibiting the more severe, late central nervous system stage, of the infection. <i>In vitro</i> assays showed that Ro-61-8048 had no direct effect on trypanosome proliferation suggesting that the anti-inflammatory action is due to a direct effect of the inhibitor on the host cells and not a secondary response to parasite destruction. These findings demonstrate that kynurenine pathway catabolites are involved in the generation of the more severe inflammatory reaction associated with the late central nervous system stages of the disease and suggest that Ro-61-8048 or a similar drug may prove to be beneficial in preventing or ameliorating the PTRE when administered as an adjunct to conventional trypanocidal chemotherap